Omada Health, Inc. (OMDA)

Omada Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Revenue	189.67	169.8	122.78
Revenue Growth (YoY)	-	38.29%	-
Cost of Revenue	-	66.92	52.81
Gross Profit	117.43	102.88	69.97
Selling, General & Admin	-	110.61	102.23
Research & Development	-	35.92	33.74
Operating Expenses	-	146.53	135.97
Operating Income	-34.06	-43.65	-66
Interest Expense / Income	3.63	3.7	-1.07
Other Expense / Income	-0.07	-0.22	2.58
Pretax Income	-37.62	-47.14	-67.51
Net Income	-37.62	-47.14	-67.51
Free Cash Flow	-33.98	-38.04	-52.66
Gross Margin	61.91%	60.59%	56.99%
Operating Margin	-17.96%	-25.71%	-53.75%
Profit Margin	-19.83%	-27.76%	-54.98%
Free Cash Flow Margin	-17.92%	-22.40%	-42.89%
EBITDA	-25.7	-35.6	-61.92
EBITDA Margin	-13.55%	-20.97%	-50.43%
Depreciation & Amortization	8.28	7.84	6.66
EBIT	-33.98	-43.44	-68.58
EBIT Margin	-17.92%	-25.58%	-55.85%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).